VIEW TAGS
Articles tagged ‘’
September 20, 2010
ARB’s In Paroxysmal AF; Results Of The ANTIPAF Trial
The ANTIPAF (ANgiotensin II anTagonists In Paroxysmal Atrial Fibrillation) trial, which reported at the ESC Stockholm meeting, was the first trial to prospectively evaluate the principal hypothesis that the angiotensin II receptor antagonist olmesartan suppresses episodes of paroxysmal AF.
September 20, 2010
EU approval for Vernakalant infusion for Rapid Conversion of Recent Onset AF
The intravenous (IV) formulation of ‘Brinavess’™ (Vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
Members Area
Log in or Register now.
GET EXCLUSIVE UPDATES
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.
RECENT COMMENTS
- None Found
PROUDLY SPONSORED BY
